{"id":"CHEMBL105","canonicalSmiles":"CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12","inchiKey":"NWIBSHFKIJFRCO-WUDYKRTCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MITOMYCIN","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jelmyto","Mitomycin","Mitosol","Mitozytrex","Mutamycin","Mytozytrex"],"synonyms":["Mitomycin","Mitomycin c","Mytozytrex","NSC-26980","UGN-101","UGN-102","Ugn-102"],"crossReferences":{"DailyMed":["mitomycin"],"PubChem":["144205046","170464814","57260126","87663"],"Wikipedia":["Mitomycin"],"drugbank":["DB00305"],"chEBI":["27504"]},"count":41,"approvedIndications":["EFO_0000616","EFO_0000516"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for glaucoma and neoplasm and has 39 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1077","canonicalSmiles":"Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1","inchiKey":"ZBPLOVFIXSTCRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMFENAC","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Saudi Arabia"," United States"],"classes":["Hepatotoxicity"," Misuse"],"year":1998},"tradeNames":["Yellox"],"synonyms":["Bromfenac","ISV-303"],"crossReferences":{"DailyMed":["bromfenac%20sodium"],"PubChem":["26757971"],"Wikipedia":["Bromfenac"],"drugbank":["DB00963"],"chEBI":["240107"]},"childChemblIds":["CHEMBL751","CHEMBL3181947"],"count":7,"approvedIndications":["EFO_0005752"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0001059","MP_0001845","MONDO_0003005","EFO_0001365","EFO_1000906","EFO_0007141","EFO_0009321","EFO_0005752"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for eye inflammation and has 6 investigational indications. It was withdrawn in Saudi Arabia and  United States initially in 1998 due to Hepatotoxicity and  Misuse."}
{"id":"CHEMBL1080884","canonicalSmiles":"Fc1ccc(OC[C@@H]2CNCCO2)c2c1CCC2","inchiKey":"HTODIQZHVCHVGM-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUBAZODONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lubazodone","YM-35992"],"crossReferences":{"drugbank":["DB09196"]},"childChemblIds":["CHEMBL1822892"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1083385","canonicalSmiles":"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1.O=S(=O)(O)O","inchiKey":"FDEODCTUSIWGLK-RSAXXLAASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOPIDOGREL BISULFATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1771","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clopidogrel bisulfate","Plavix"],"synonyms":["Clopidogrel bisulfate","Clopidogrel hydrogen sulfate","Clopidogrel sulfate","SR 25990C","SR-25990C"],"crossReferences":{"DailyMed":["clopidogrel%20bisulfate"],"PubChem":["144205123","170465231"],"chEBI":["3759"]},"count":8,"approvedIndications":["EFO_1000985","EFO_0000712","EFO_0000556","EFO_0000612","EFO_0005672","EFO_0004265"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","HP_0002239","EFO_1000985","EFO_0001645","EFO_0000712","EFO_0000556","EFO_0008583","EFO_0000612","EFO_0005672","EFO_0004265"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 6 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1095280","canonicalSmiles":"Nc1ncnc2c1ncn2C[C@@H](O)[C@@H](O)C(=O)O","inchiKey":"LIEMBEWXEZJEEZ-INEUFUBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERITADENINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eritadenine"],"crossReferences":{"drugbank":["DB03769"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1130","canonicalSmiles":"C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O","inchiKey":"ZWAOHEXOSAUJHY-ZIYNGMLESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXIFLURIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5'-Deoxy-5-Fluorouridine","Capecitabine related compound b","Doxifluridine","RO 219738","RO-219738"],"crossReferences":{"PubChem":["144204782","170465861","29215154","50106323","50106324","56320807","56322615","90341388"],"drugbank":["DB12947"],"chEBI":["31521"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1159650","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"CBGUOGMQLZIXBE-XGQKBEPLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOBETASOL PROPIONATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clarelux","Clobaderm","Clobetasol propionate","Clobetasol propionate (emollient)","Clobex","Cormax","Dermovate","Dermovate nn","Embeline","Embeline e","Etrivex","Impeklo","Impoyz","Olux","Olux e","Temovate","Temovate e"],"synonyms":["CCI 4725","CCI-4725","Clobetasol","Clobetasol 17-propionate","Clobetasol propionate","GR 2/925"],"crossReferences":{"DailyMed":["clobetasol%20propionate"],"PubChem":["144204967","170465385","56422175","855884"],"Wikipedia":["Clobetasol_propionate"],"drugbank":["DB01013"],"chEBI":["31414"]},"count":18,"approvedIndications":["EFO_1001494","EFO_0000676"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0001059","EFO_0000685","EFO_1001494","EFO_1000764","EFO_1000724","EFO_1000657","EFO_0000701","EFO_0000274","EFO_1000706","EFO_1000623","EFO_0007187","EFO_1001347","EFO_0004192","Orphanet_79364","MONDO_0002406","EFO_0000676","EFO_1001993","EFO_1000766","EFO_1000726","EFO_0008517","EFO_0004775","EFO_1001949"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for psoriasis and psoriasis vulgaris and has 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1189","canonicalSmiles":"CCNCC","inchiKey":"HPNMFZURTQLUMO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diethyl-Amine","Diethylamine"],"crossReferences":{"PubChem":["144209704","17389600"],"Wikipedia":["Diethylamine"],"chEBI":["85259"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL119596","canonicalSmiles":"CCOCCO","inchiKey":"ZNQVEEAIQZEUHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-ETHOXYETHANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210351","17389338"],"Wikipedia":["2-Ethoxyethanol"],"drugbank":["DB02249"],"chEBI":["46788"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1197091","canonicalSmiles":"O=C(CC1NCCCC1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O","inchiKey":"LVASCWIMLIKXLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOFUGINONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HT-100","Halofuginone","Ht-100"],"childChemblIds":["CHEMBL1162013","CHEMBL559362"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1200323","canonicalSmiles":"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl","inchiKey":"WQVZLXWQESQGIF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LABETALOL HYDROCHLORIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL429","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Labetalol Hydrocloride","Labetalol hydrochloride","Labrocol","Normodyne","Trandate"],"synonyms":["AH 5158A","AH-5158A","AH-5158A HYDROCHLORIDE","Labetalol hydrochloride","NSC-290312","SCH 15719W","SCH-15719W","SCH-15719W HYDROCHLORIDE"],"crossReferences":{"DailyMed":["labetalol%20hydrochloride"],"PubChem":["144204174","144213042","26747550","50106500","56422413","855542"]},"count":2,"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0005669","EFO_0000668"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 2 investigational indications."}
{"id":"CHEMBL1200478","canonicalSmiles":"CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1.Cl","inchiKey":"KNZADIMHVBBPOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DYCLONINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201217","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dyclone"],"synonyms":["Dyclocaine","Dyclonine HCl","Dyclonine hydrochloride"],"crossReferences":{"DailyMed":["dyclonine%20hydrochloride"],"PubChem":["144204010","170464776","26748011","26748012","50107329","50107330","56422189","855952"],"chEBI":["4725"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200559","canonicalSmiles":"CC(O)C(=O)O","inchiKey":"JVTAAEKCZFNVCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACTIC ACID","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dl- lactic acid","Dl-lactic acid","E 270","E-270","E270","FEMA NO. 2611","HIPURE 88","INS NO.270","INS-270","Lactic acid","NSC-367919","PURAC FCC 80","PURAC FCC 88"],"crossReferences":{"DailyMed":["lactic%20acid"],"PubChem":["144204600","144209653","144213921","170466852","17389538"],"drugbank":["DB04398"],"chEBI":["78320"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 2 investigational indications."}
{"id":"CHEMBL1200616","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)N=C[N-]S2(=O)=O.[Na+]","inchiKey":"CPIWHAFLBZQYLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROTHIAZIDE SODIUM","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL842","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorothiazide sodium","Diuril"],"synonyms":["Chlorothiazide sodium"],"crossReferences":{"DailyMed":["chlorothiazide%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958."}
{"id":"CHEMBL1200721","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2OP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"IIUMCNJTGSMNRO-VVSKJQCTSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTRAMUSTINE PHOSPHATE SODIUM","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1756","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emcyt"],"synonyms":["Estramustine 17-(dihydrogenphosphate) disodium salt anhydrous","Estramustine 17-(dihydrogenphosphate) disodium salt monohydrate","Estramustine phosphate sodium","Estramustine phosphate sodium hydrate","RO 21-8837/001","RO-218837-001"],"crossReferences":{"DailyMed":["estramustine%20phosphate%20sodium"],"PubChem":["144206926"],"chEBI":["31562"]},"count":6,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000673","MONDO_0007254","MONDO_0002367","EFO_0000574","MONDO_0008315"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for neoplasm and has 5 investigational indications."}
{"id":"CHEMBL1200751","canonicalSmiles":"O.Sc1ncnc2nc[nH]c12","inchiKey":"WFFQYWAAEWLHJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERCAPTOPURINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1425","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mercaptopurine","Puri-nethol","Purinethol","Purixan","Xaluprine"],"synonyms":["6-mercaptopurine","6-mercaptopurine monohydrate","Mercaptopurine","Mercaptopurine anhydrous","Mercaptopurine hydrate","NSC-755"],"crossReferences":{"DailyMed":["mercaptopurine"],"PubChem":["103804943","57260342"],"chEBI":["31822"]},"count":21,"approvedIndications":["EFO_0000616","MONDO_0000873","EFO_0000220","MONDO_0000870"],"linkedTargets":{"rows":["ENSG00000128059"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","MONDO_0000873","EFO_0000209","MONDO_0003541","EFO_0000565","EFO_1000318","MONDO_0003268","MONDO_0019460","EFO_0004289","EFO_0000330","EFO_0002499","MONDO_0020743","EFO_0000094","EFO_0010580","EFO_0000616","EFO_0000220","EFO_0000222","MONDO_0000870","EFO_1001946","EFO_0002501","EFO_0000384","EFO_0000224","MONDO_0044917","EFO_1001936","EFO_1001947","EFO_0000574","EFO_0000519","EFO_0003872"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 4 approved and 17 investigational indications."}
{"id":"CHEMBL1200976","canonicalSmiles":"CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O.Cl","inchiKey":"JVHPTYWUBOQMBP-RVFAQHLVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IDARUBICIN HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1117","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Idamycin","Idamycin pfs","Idarubicin hydrochloride","Idarubicin hydrochloride pfs","Zavedos"],"synonyms":["IMI 30","IMI-30","Idarubicin hydrochloride","NSC-256439"],"crossReferences":{"DailyMed":["idarubicin%20hydrochloride"],"PubChem":["144204787","170464627","49681632"]},"count":2,"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["MONDO_0019457","MONDO_0044887","EFO_0000222","MONDO_0004643"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201147","canonicalSmiles":"CCCCC(CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1","inchiKey":"FMJSMJQBSVNSBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTOCRYLENE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Octocrilene","Octocrylene"],"crossReferences":{"PubChem":["144204704","144207434","170464719","17389332","29215118","85147156"],"Wikipedia":["Octocrylene"]},"count":1,"approvedIndications":["EFO_0003963"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2006 and is indicated for freckles."}
{"id":"CHEMBL1201148","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"PIDANAQULIKBQS-RNUIGHNZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPREDNISONE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betapar"],"synonyms":["Meprednisone","NSC-527579","SCH 4358","SCH-4358"],"crossReferences":{"PubChem":["144207161","170465165"],"Wikipedia":["Meprednisone"],"drugbank":["DB09383"]},"count":1,"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000756"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL1201474","drugType":"Unknown","blackBoxWarning":false,"name":"COLESTIPOL HYDROCHLORIDE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Colestid","Colestid Flavored Colestid","Colestid orange","Colestipol hydrochloride","Flavored colestid"],"synonyms":["Colestipol","Colestipol hydrochloride"],"crossReferences":{"DailyMed":["colestipol%20hydrochloride"],"DrugCentral":["728"]},"count":6,"approvedIndications":["HP_0003124"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and is indicated for hypercholesterolemia and has 5 investigational indications."}
{"id":"CHEMBL1201613","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN GLULISINE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apidra","Apidra solostar","Ins apidra","Ins apidra opticlik","Ins apidra optiset","Ins apidra solostar"],"synonyms":["HMR 1964","HMR-1964","HMR1964","Insulin Glulisine Recombinant","Insulin glulisine","Insulin glulisine recombinant"],"crossReferences":{"DailyMed":["insulin%20glulisine%20recombinant"],"DrugCentral":["5057"]},"count":6,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0001359","EFO_0000249","EFO_0001064","EFO_0000612","EFO_0001360","EFO_0000400"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for diabetes mellitus and has 5 investigational indications."}
{"id":"CHEMBL1201760","canonicalSmiles":"N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1","inchiKey":"QFFGVLORLPOAEC-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BESIFLOXACIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Besifloxacin","ISV-403"],"crossReferences":{"DailyMed":["besifloxacin%20hydrochloride"],"Wikipedia":["Besifloxacin"],"drugbank":["DB06771"]},"childChemblIds":["CHEMBL1201761"],"count":2,"approvedIndications":["EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for eye infection and has 1 investigational indication."}
{"id":"CHEMBL1201831","drugType":"Antibody","blackBoxWarning":true,"name":"CERTOLIZUMAB PEGOL","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cimzia"],"synonyms":["CDP 870","CDP-870","CDP870","Certolizumab pegol","PHA-738144"],"crossReferences":{"DailyMed":["certolizumab%20pegol"],"DrugCentral":["4968"],"Wikipedia":["Certolizumab_pegol"]},"count":9,"approvedIndications":["EFO_0000685","EFO_0003898","EFO_0003778","EFO_0000540","EFO_0000384"],"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000685","Orphanet_247353","EFO_0000756","EFO_0003898","EFO_0000676","EFO_0003778","EFO_1000869","EFO_0000540","EFO_0000384","EFO_0002609"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 5 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1204498","canonicalSmiles":"O=C(Nc1ccc(Oc2ncccn2)cc1C(=O)O)c1ccc(Cl)cc1Cl","inchiKey":"VNDRRWBKNSHALL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1204498","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08402"]},"childChemblIds":["CHEMBL118206"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213900","canonicalSmiles":"[2H]C([2H])([2H])OC[C@@H](NC(C)=O)C(=O)NCc1ccccc1","inchiKey":"VPPJLAIAVCUEMN-IBIJPGRPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213900","maximumClinicalTrialPhase":0,"parentId":"CHEMBL58323","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1222336","canonicalSmiles":"N[C@@H]1CONC1=O.O","inchiKey":"YPTKVXJEZFSVMA-HSHFZTNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1222336","maximumClinicalTrialPhase":0,"parentId":"CHEMBL771","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230658","canonicalSmiles":"CCCCCNC(=O)[C@H](Cc1ccc(N(C(=O)C(=O)O)c2ccccc2C(=O)O)c2ccccc12)NC(C)=O","inchiKey":"UESXELNYBIOROE-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230658","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01820"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233097","canonicalSmiles":"N=C(N)c1ccc(NC(=O)Nc2ccc(Oc3ccccc3)cc2)cc1","inchiKey":"ZHCAYBOLUMAUQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233097","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03337"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234089","canonicalSmiles":"N=C(N)NS(=O)(=O)c1ccc(N/C=C2\\C(=O)Nc3ccccc32)cc1","inchiKey":"DMCRNUMVSATRTP-LCYFTJDESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234089","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08126"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234283","canonicalSmiles":"CO[C@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"OHWCAVRRXKJCRB-XUVCUMPTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234283","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03194"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235255","canonicalSmiles":"COCCOCCOCCOC","inchiKey":"YFNKIDBQEZZDLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235255","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26757434"],"drugbank":["DB02078"],"chEBI":["44842"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235429","canonicalSmiles":"CC(=O)O[C@@]12[C@H](O)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C","inchiKey":"SDSVJYOOAPRSDA-RPCQODIISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"13-Acetylphorbol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["13-Acetylphorbol"],"crossReferences":{"drugbank":["DB04376"],"chEBI":["45127"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235735","canonicalSmiles":"O=C(CC1(S(=O)(=O)c2ccc(Oc3ccccc3)cc2)CCOCC1)NO","inchiKey":"ARIRIZBKMKMEBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235735","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08491"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1255939","canonicalSmiles":"CCn1cc(C(=O)[O-])c(=O)c2ccc(C)nc21.[Na+]","inchiKey":"ROKRAUFZFDQWLE-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"NALIDIXATE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL5","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nalidixate sodium","WIN 18,320-3"],"crossReferences":{"PubChem":["11112058","124881882","26732617","50106683"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256696","canonicalSmiles":"CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"AKJDEXBCRLOVTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBETAPENTANE CITRATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL73234","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Toclase"],"synonyms":["Carbetapentane citrate","Pentoxyverine","Pentoxyverine citrate"],"crossReferences":{"PubChem":["11112007","11113006","124881868","26747484","26747485","46500452","50106075","85231297","85273776"]},"count":1,"approvedIndications":["EFO_0007486"],"linkedTargets":{"rows":["ENSG00000147955"],"count":1},"linkedDiseases":{"rows":["EFO_0007486"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for sinusitis. It was withdrawn in United States."}
{"id":"CHEMBL1257069","canonicalSmiles":"COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1.Cl","inchiKey":"VQAAEWMEVIOHTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFTOPIDIL DIHYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL142635","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naftopidil Dihydrochloride"],"crossReferences":{"PubChem":["855937"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1321","canonicalSmiles":"CNNCc1ccc(C(=O)NC(C)C)cc1","inchiKey":"CPTBDICYNRMXFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCARBAZINE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Matulane","Procarbazine","RO-4-6467","RO-4-6467 FREE BASE"],"crossReferences":{"DailyMed":["procarbazine%20hydrochloride"],"PubChem":["11112335","144212055","174007426"],"Wikipedia":["Procarbazine"],"drugbank":["DB01168"],"chEBI":["71417"]},"childChemblIds":["CHEMBL1200410"],"count":6,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and is indicated for neoplasm and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL132767","canonicalSmiles":"CCN(CC)c1cc(C)nc2ncnn12","inchiKey":"GSNOZLZNQMLSKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAPIDIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR 12008","Trapidil","Trapymin"],"crossReferences":{"PubChem":["11112623","14745540","170465770","50086436"],"drugbank":["DB09283"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL13376","canonicalSmiles":"COc1ccc2c(C(=O)c3ccc(Cl)cc3)c(C)n(CC(=O)O)c2c1","inchiKey":"DGMZLCLHHVYDIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMETACIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1987},"tradeNames":[],"synonyms":["C 1656","Clometacin","Mindolic acid","R 3959"],"crossReferences":{"PubChem":["144206860"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1987 due to Hepatotoxicity."}
{"id":"CHEMBL1472830","canonicalSmiles":"CS(=O)(=O)NC(=O)CCC/C=C\\C[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1ccccc1","inchiKey":"UQZVCDCIMBLVNR-TWYODKAFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULPROSTONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-34,089","Sulprostone","ZK 57 671"],"crossReferences":{"PubChem":["29217657"],"drugbank":["DB12708"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1472989","canonicalSmiles":"CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"VMDFASMUILANOL-WXXKFALUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISOPROLOL FUMARATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL645","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bipranix","Bisoprolol fumarate","Cardicor","Concor","Congescor","Emcor","Emcor ls","Isoten mitis","Monocor","Soloc","Soprol","Vivacor","Zebeta"],"synonyms":["Bisoprolol fumarate","Bisoprolol hemifumarate","CL 297,939","CL-297939","EMD-33-512","EMD-33512"],"crossReferences":{"DailyMed":["bisoprolol%20fumarate"],"PubChem":["144204814","144206959","170464815","26753629"],"chEBI":["3128"]},"count":3,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","Orphanet_79292","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for hypertension and has 2 investigational indications."}
{"id":"CHEMBL1489662","canonicalSmiles":"O=C(Cc1ccc(-c2ccccc2)cc1)Nc1ccccn1","inchiKey":"PWHROYKAGRUWDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFENPIRAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Difenpiramide"],"crossReferences":{"PubChem":["49672633"],"drugbank":["DB13371"],"chEBI":["76130"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1499","canonicalSmiles":"C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"MFYSYFVPBJMHGN-ZPOLXVRWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1499","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205092","144211757","170466316","26751583","50104218","50104219","50104220","56422112","75082","855981","90341612"],"drugbank":["DB14681"],"chEBI":["16962"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1528839","canonicalSmiles":"Cl.N=C(N)NC(=N)NCCc1ccccc1","inchiKey":"YSUCWSWKRIOILX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENFORMIN HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL170988","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," Germany"," France"],"classes":["Metabolism toxicity"],"year":1977},"tradeNames":["Dibotin s.r."],"synonyms":["Phenformin hydrochloride"],"crossReferences":{"PubChem":["144204035","144204736","144209395","144213321","170466230","17389768","26757813","56463711","855734"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States,  Germany and  France initially in 1977 due to Metabolism toxicity."}
{"id":"CHEMBL1593906","canonicalSmiles":"CCC(=O)O[C@@](Cc1ccccc1)(c1ccccc1)[C@@H](C)CN(C)C.O=S(=O)(O)c1ccc2ccccc2c1","inchiKey":"VZPXFHVJUUSVLH-VNJAQMQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOPROPOXYPHENE NAPSYLATE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1738990","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Novrad"],"synonyms":["29866","Levopropoxyphene napsylate","Levopropoxyphene napsylate anhydrous"],"crossReferences":{"PubChem":["11112964","144204309"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1607","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1.Cl","inchiKey":"DGHHQBMTXTWTJV-BQAIUKQQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOPOTECAN HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL84","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hycamptin","Hycamtin","Topotecan","Topotecan hydrochloride"],"synonyms":["Nogitecan hydrochloride","SK&F S-104864-A","SK&F-S-104864A","SK-S-104864-A","Topotecan hydrochloride"],"crossReferences":{"DailyMed":["topotecan%20hydrochloride"],"PubChem":["144205031","170465137","26749084","4254372","49681835","50107520","580652"]},"count":58,"linkedTargets":{"rows":["ENSG00000184428"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0001075","EFO_0000681","MONDO_0000956","EFO_1000657","MONDO_0004222","EFO_0005952","EFO_0000565","MONDO_0002974","EFO_1001331","MONDO_0008903","EFO_0002918","Orphanet_654","EFO_0001416","EFO_0000198","EFO_0003893","EFO_0000466","EFO_0000220","EFO_1000823","MONDO_0018271","MONDO_0008170","EFO_0000502","MONDO_0008315","Orphanet_357034","EFO_0000630","Orphanet_398934","MONDO_0015917","EFO_0001061","EFO_1001100","EFO_0003851","EFO_0008524","EFO_0002428","EFO_0000574","EFO_0001378","EFO_1000172","MONDO_0015686","EFO_1001465","MONDO_0007254","Orphanet_790","MONDO_0021063","MONDO_0002087","EFO_1000357","EFO_0007362","MONDO_0002158","EFO_1000043","EFO_0000326","EFO_0002499","EFO_1001963","EFO_1000158","EFO_0000616","EFO_1001042","EFO_0000222","EFO_0000313","MONDO_0007576","EFO_0002501","EFO_0000621","EFO_0003060","EFO_0000311","EFO_0000174","MONDO_0011962","EFO_0000702","EFO_1002008","MONDO_0019004","MONDO_0024880","EFO_0000691","EFO_0000519","EFO_0003833"],"count":67},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 58 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1627080","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]","inchiKey":"FYWLYWMEGHCZAX-MCDZGGTQSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"Adenosine-5'-Monophosphate Disodium Salt","maximumClinicalTrialPhase":0,"parentId":"CHEMBL752","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adenosine-5'-Monophosphate Disodium Salt"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1726","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]","inchiKey":"VKQFCGNPDRICFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NISOLDIPINE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nisoldipine","Sular","Syscor mr 10","Syscor mr 20","Syscor mr 30"],"synonyms":["BAY K 5552","BAY-K-5552","Nisoldipine"],"crossReferences":{"DailyMed":["nisoldipine"],"PubChem":["144205804","144212682","170465320","26758055"],"Wikipedia":["Nisoldipine"],"drugbank":["DB00401"],"chEBI":["76917"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0000401","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1743045","drugType":"Antibody","blackBoxWarning":false,"name":"NAPTUMOMAB ESTAFENATOX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABR-217620","ANYARA","ANYARA TTS CD3","Naptumomab estafenatox","TTS CD3","TTS-CD3"],"count":2,"linkedTargets":{"rows":["ENSG00000146242"],"count":1},"linkedDiseases":{"rows":["EFO_0000681","EFO_0003060"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743059","drugType":"Antibody","blackBoxWarning":false,"name":"RACOTUMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Racotumomab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL184412","canonicalSmiles":"CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1","inchiKey":"ZQTNQVWKHCQYLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DRONEDARONE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dronedarone","SR-33589","SR33589"],"crossReferences":{"DailyMed":["dronedarone%20hydrochloride"],"PubChem":["144206559","170465064"],"Wikipedia":["Dronedarone"],"drugbank":["DB04855"],"chEBI":["50659"]},"childChemblIds":["CHEMBL1201729"],"count":4,"approvedIndications":["EFO_0004269"],"linkedTargets":{"rows":["ENSG00000136546","ENSG00000157388","ENSG00000151067","ENSG00000123700","ENSG00000168356","ENSG00000007314","ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000081248","ENSG00000102001","ENSG00000144285","ENSG00000169432","ENSG00000138622","ENSG00000136531","ENSG00000153253"],"count":16},"linkedDiseases":{"rows":["EFO_0003911","EFO_0000275","EFO_0004269","EFO_0000373"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for cardiac arrhythmia and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL186483","canonicalSmiles":"CS(=O)(=O)c1ccc(C(=N)N)cc1","inchiKey":"ANPBNAUKOUYEGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Methanesulfonyl-Benzamidine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Methanesulfonyl-Benzamidine"],"crossReferences":{"drugbank":["DB07368"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1887147","canonicalSmiles":"CS(=O)(=O)c1cc(C(F)(F)F)ccc1C(=O)c1cnoc1C1CC1","inchiKey":"OYIKARCXOQLFHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOXAFLUTOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["264-EUP-99","Isoxaflutole","Merlin","RPA-201772"],"crossReferences":{"PubChem":["144211240","26757421"],"drugbank":["DB12938"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1908333","canonicalSmiles":"CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CCN2C[C@@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC","inchiKey":"JTSDBFGMPLKDCD-XVFHVFLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILMICOSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Micotil"],"synonyms":["EL870","Tilmicosin"],"crossReferences":{"PubChem":["144205099"],"drugbank":["DB11471"]},"childChemblIds":["CHEMBL2105782"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1909324","canonicalSmiles":"COc1cc(Br)c(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)cc1OC","inchiKey":"DDHUTBKXLWCZCO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINAVERIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pinaverium"],"crossReferences":{"drugbank":["DB09090"]},"childChemblIds":["CHEMBL1909298"],"count":1,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL195450","canonicalSmiles":"O=C(Nc1ccc2[nH]ccc2c1)c1cc(F)cc(N2CCOCC2)c1","inchiKey":"VMLSXFMXUNVCSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL195450","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL197550","canonicalSmiles":"O=C(O)c1ccc(Cc2ccccc2Cl)o1","inchiKey":"YRUPEIZURHOLHV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL197550","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07308"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL199544","canonicalSmiles":"O=C(O)c1ccc(-c2ccc([N+](=O)[O-])cc2Cl)o1","inchiKey":"HDIHNBCCQWMVBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL199544","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07305"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC","inchiKey":"IENZQIKPVFGBNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAZOSIN","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-12299","CP-122991","Prazosin"],"crossReferences":{"DailyMed":["prazosin%20hydrochloride"],"PubChem":["11112649","11112650","11113367","124882482","124882484","124882486","124882487","144207195","170465415","26751613","26751614","50100502","50104272","50104273","50104274","50104275","90340959"],"Wikipedia":["Prazosin"],"drugbank":["DB00457"],"chEBI":["8364"]},"childChemblIds":["CHEMBL1558","CHEMBL1347191"],"count":7,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0000537","EFO_0005854","MONDO_0100096","HP_0000726","EFO_0004253","EFO_0003768","EFO_0001358","EFO_0004701","EFO_0005230","HP_0000011","EFO_0003829","EFO_0005223"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for hypertension and has 6 investigational indications."}
{"id":"CHEMBL2008565","canonicalSmiles":"N=C(N)NCC1CCCCCCN1","inchiKey":"ZCVAIGPGEINFCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANAZODINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guanazodine"],"crossReferences":{"drugbank":["DB13604"]},"childChemblIds":["CHEMBL2000371"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL209821","canonicalSmiles":"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1","inchiKey":"SPWZXWDPAWDKQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALUZOTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naluzotan","PRX-00023"],"crossReferences":{"drugbank":["DB05562"]},"childChemblIds":["CHEMBL2105647"],"count":3,"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0005230","EFO_0000773"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2104231","canonicalSmiles":"CC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@@]21C","inchiKey":"JWAHBTQSSMYISL-MHTWAQMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMEGESTONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Demegestone","R 2453"],"crossReferences":{"drugbank":["DB13857"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104956","canonicalSmiles":"CCCCC(CC)COc1ccc(-c2nc(-c3ccc(OC)cc3)nc(-c3ccc(OCC(CC)CCCC)cc3O)n2)c(O)c1","inchiKey":"XVAMCHGMPYWHNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEMOTRIZINOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tinosorb s"],"synonyms":["BEMT","Bemotrizinol","FAT 70'884","FAT-70884"],"crossReferences":{"drugbank":["DB11206"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104984","canonicalSmiles":"Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)cc3F)nc2C)ccc1OC(C)(C)C(=O)O","inchiKey":"ZUGQWAYOWCBWGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODELGLITAZAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-677954","GW677954","Sodelglitazar"],"count":2,"linkedTargets":{"rows":["ENSG00000112033","ENSG00000186951","ENSG00000132170"],"count":3},"linkedDiseases":{"rows":["EFO_0000195","EFO_0001360"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105302","canonicalSmiles":"c1ccc(C(Cc2noc(CCN3CCCCC3)n2)c2ccccc2)cc1","inchiKey":"PXZDWASDNFWKSD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRENOXDIAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prenoxdiazine"],"crossReferences":{"drugbank":["DB13397"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105351","canonicalSmiles":"[Na+].[O-]n1ccccc1=S","inchiKey":"XNRNJIIJLOFJEK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRITHIONE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1650619","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sodium omadine"],"synonyms":["AL02725","Pyrithione sodium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105661","canonicalSmiles":"CCNCCS(=O)(=O)NC[C@@]1(c2ccccc2)SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C","inchiKey":"YVAFBXLHPINSIK-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LITRONESIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KF 89617","KF-89617","KF89617","LY 2523355","LY-2523355","LY2523355","Litronesib"],"crossReferences":{"drugbank":["DB11861"]},"count":12,"linkedTargets":{"rows":["ENSG00000138160"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","MONDO_0001056","EFO_0006859","MONDO_0008170","EFO_0000702","MONDO_0007254","MONDO_0007576","MONDO_0024880","MONDO_0008315","EFO_0003060","EFO_1001951","EFO_0000311"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL2105683","canonicalSmiles":"COc1ccc2cc([C@H](C)C(=O)OCCS(C)(=O)=O)ccc2c1","inchiKey":"JGBUBSOKFSVXKS-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPROXEN ETEMESIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LT-NS001","MX-1094","Naproxen etemesil"],"crossReferences":{"drugbank":["DB12398"]},"count":1,"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0002506"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106111","canonicalSmiles":"CC(O)C(=O)[O-].CC(O)C(=O)[O-].[Ca+2]","inchiKey":"MKJXYGKVIBWPFZ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM LACTATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prequist powder"],"synonyms":["Calcium lactate","E-327","INS NO.327","INS-327","INS-327-"],"crossReferences":{"DrugCentral":["4383"],"PubChem":["144208576","144213213"],"drugbank":["DB13231"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2107243","canonicalSmiles":"Nc1ccc(S(=O)(=O)[N-]c2nccs2)cc1.[Na+]","inchiKey":"GWIJGCIVKLITQK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFATHIAZOLE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL437","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfathiazole sodium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107350","canonicalSmiles":"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl.O=C(O)C[C@H](O)C(=O)O","inchiKey":"ICLGPDCMPQYWIA-OSRSGTIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVAMLODIPINE MALATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL2111097","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Levamlodipine malate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107356","canonicalSmiles":"Cl.O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O","inchiKey":"QQPHRRSYJMOQOC-DKIIUIKKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILVETEROL HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1940832","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK159797C","Milveterol hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107360","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(c3noc4cc(F)ccc34)CC1)c2=O","inchiKey":"VOMKSBFLAZZBOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PALIPERIDONE PALMITATE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Invega sustenna","Invega trinza"],"synonyms":["JNS-010","JNS010","Paliperidone palmitate","Palperidone palmitate","R-092670","R092670","RO-92670","RO92670"],"crossReferences":{"DailyMed":["paliperidone%20palmitate"],"chEBI":["83808"]},"count":2,"approvedIndications":["EFO_0000692","EFO_0005411"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0000289","EFO_0000692","EFO_0005411"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for schizoaffective disorder and schizophrenia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2107448","canonicalSmiles":"CN1CCN(/C=C2\\N=C3CN=C(c4ccccc4Cl)c4cc([N+](=O)[O-])ccc4N3C2=O)CC1","inchiKey":"UTEFBSAVJNEPTR-RGEXLXHISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOPRAZOLAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Loprazolam"],"crossReferences":{"drugbank":["DB13643"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107614","canonicalSmiles":"CCOC(=O)[C@@]1(OC(=O)C(Cl)Cl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"QAIOVDNCIZSSSF-RFAJLIJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIPREDNOL DICLOACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BNP-166","Etiprednol dicloacetate"],"crossReferences":{"drugbank":["DB05442"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107743","canonicalSmiles":"CC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)NCC(=O)O)[C@@H](C)CC)[C@@H](C)CC","inchiKey":"ZKGHZWHJOPXFIK-KMICFFLZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"EDRATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edratide","TV-4710"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107844","drugType":"Protein","blackBoxWarning":false,"name":"BRIOBACEPT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BR-3-FC","BR3-FC","Briobacept","SS-79"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108167","drugType":"Antibody","blackBoxWarning":false,"name":"VEPALIMOMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vepalimomab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108258","drugType":"Antibody","blackBoxWarning":false,"name":"ATOROLIMUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atorolimumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108791","drugType":"Enzyme","blackBoxWarning":false,"name":"TENECTEPLASE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metalyse"],"synonyms":["TNK-TPA","Tenecteplase"],"crossReferences":{"DailyMed":["tenecteplase"],"DrugCentral":["5066"]},"count":12,"approvedIndications":["MONDO_0000831","HP_0004419"],"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["HP_0002140","EFO_0004278","MONDO_0002679","EFO_1001154","EFO_0000618","EFO_1000637","EFO_0008585","MONDO_0000831","EFO_0003827","EFO_0000712","MONDO_0005299","EFO_0008583","EFO_0000612","HP_0004419","EFO_0009637"],"count":15},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for recurrent thrombophlebitis and thrombotic disease and has 10 investigational indications."}
{"id":"CHEMBL2109032","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM POLYCARBOPHIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Mitrolan","Noveon ca-1","Noveon ca-2","Sorboquel"],"synonyms":["Calcium polycarbophil","WI 140"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109255","drugType":"Antibody","blackBoxWarning":false,"name":"HEFI-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HEFI-1","Hefi-1"],"count":2,"linkedTargets":{"rows":["ENSG00000120949"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000574"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109282","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7636","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DEDN-6526A","RG-7636"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109325","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-191","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-191","Amg-191"],"count":1,"linkedTargets":{"rows":["ENSG00000157404"],"count":1},"linkedDiseases":{"rows":["Orphanet_183660"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109486","drugType":"Antibody","blackBoxWarning":false,"name":"CDP-850","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDP-850"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL219544","canonicalSmiles":"Nc1nc2c(c(=O)[nH]1)CC=N2","inchiKey":"LOSIULRWFAEMFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-DEAZAGUANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02245"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221245","canonicalSmiles":"CCc1ccc(/C=C2\\SC(N[C@H](C(=O)O)c3ccc(F)cc3)=NC2=O)o1","inchiKey":"RNEACARJKXYVND-MZLJFPOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL221245","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08706"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221735","canonicalSmiles":"NCC1CCN(Cc2ccc3[nH]c(-c4cc5ccccc5[nH]c4=O)cc3c2)CC1","inchiKey":"KBIHHEGEALBUMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL221735","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07025"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2219414","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12.Cl.Cl","inchiKey":"JYCNMRVZELJVAW-RZVFYPHASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERAVACYCLINE DIHYDROCHLORIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1951095","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xerava"],"synonyms":["Eravacycline dihydrochloride","TP-434-046"],"crossReferences":{"DailyMed":["eravacycline%20dihydrochloride"]},"count":1,"approvedIndications":["EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for infection."}
{"id":"CHEMBL2227975","canonicalSmiles":"Cc1c(COC(=O)[C@@H]2[C@H](/C=C(\\Cl)C(F)(F)F)C2(C)C)cccc1-c1ccccc1","inchiKey":"OMFRMAHOUUJSGP-IRHGGOMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIFENTHRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15056"],"chEBI":["3093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL222913","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSC(=O)c3ccco3)CS[C@H]12)c1csc(N)n1","inchiKey":"ZBHXIWJRIFEVQY-IHMPYVIRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTIOFUR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ceftiofur"],"crossReferences":{"PubChem":["144206093"],"Wikipedia":["Ceftiofur"],"drugbank":["DB11485"]},"childChemblIds":["CHEMBL2105998","CHEMBL2106486"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL224867","canonicalSmiles":"C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O","inchiKey":"WBWWGRHZICKQGZ-HZAMXZRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAUROCHOLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cholaic acid","Cholic acid taurine conjugate","N-Choloyltaurine","Taurocholic acid"],"crossReferences":{"Wikipedia":["Taurocholic_acid"],"drugbank":["DB04348"],"chEBI":["28865"]},"childChemblIds":["CHEMBL443728","CHEMBL1361792"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2338329","canonicalSmiles":"Cc1nc(C(=O)NCC(=O)O)c(O)c2ccc(Oc3ccccc3)cc12","inchiKey":"YOZBGTLTNGAVFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROXADUSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-1517","ASP1517","FG-4592","FG4592","Roxadustat"],"crossReferences":{"PubChem":["174006837"],"drugbank":["DB04847"]},"count":4,"linkedTargets":{"rows":["ENSG00000135766","ENSG00000178467","ENSG00000129521","ENSG00000269858"],"count":4},"linkedDiseases":{"rows":["EFO_0000198","EFO_0003086","EFO_0003884","EFO_0004272"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2348782","canonicalSmiles":"C[C@]12CCC(=O)C=C1CC[C@@H]1C2=CC[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO","inchiKey":"BCFCRXOJOFDUMZ-ONKRVSLGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2348782","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12081"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2354773","drugType":"Small molecule","blackBoxWarning":false,"name":"AUROTHIOGLUCOSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aureotan 100","Solganal"],"synonyms":["Aurothioglucose","Gold thioglucose"],"crossReferences":{"DrugCentral":["4349"],"PubChem":["144205102"]},"count":1,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000198431"],"count":1},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease."}
{"id":"CHEMBL2356023","canonicalSmiles":"CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3\\C[C@@H](O)CC[C@@H]3C)CCC[C@@]21C","inchiKey":"ILYCWAKSDCYMBB-OPCMSESCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROTACHYSTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A.t. 10","Dihydral","Dygratyl","Hytakerol","Tachyrol"],"synonyms":["Dichysterol","Dihydrotachysterol","Vitamin d1"],"crossReferences":{"PubChem":["144205894"],"drugbank":["DB01070"],"chEBI":["4591"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL238804","canonicalSmiles":"CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1","inchiKey":"QXWZQTURMXZVHJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELEXIPAG","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uptravi"],"synonyms":["ACT-293987","NS-304","Selexipag"],"crossReferences":{"DailyMed":["selexipag"],"drugbank":["DB11362"]},"count":4,"approvedIndications":["Orphanet_275766","Orphanet_422","HP_0004419"],"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","Orphanet_275766","Orphanet_422","HP_0004419"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL24072","canonicalSmiles":"CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1","inchiKey":"IFFPICMESYHZPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRENYLAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," Germany"," France"," Malaysia"],"classes":["Cardiotoxicity"],"year":1988},"tradeNames":[],"synonyms":["B-436","Prenylamine","Prenylamine lactate"],"crossReferences":{"Wikipedia":["Prenylamine"],"drugbank":["DB04825"]},"childChemblIds":["CHEMBL1367944"],"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000183873","ENSG00000198668"],"count":2},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease. It was withdrawn in United Kingdom,  Germany,  France and  Malaysia initially in 1988 due to Cardiotoxicity."}
{"id":"CHEMBL247378","canonicalSmiles":"O=[N+]([O-])c1cccc2cn[nH]c12","inchiKey":"PQCAUHUKTBHUSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-NITROINDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-Nitroindazole"],"crossReferences":{"PubChem":["11111551","11113328","26746920","50103946","56422885","855595","90340658"],"Wikipedia":["7-Nitroindazole"],"drugbank":["DB02207"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL25028","canonicalSmiles":"CS(C)(=O)=O","inchiKey":"HHVIBTZHLRERCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHANESULFONYLMETHANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methanesulfonylmethane"],"crossReferences":{"PubChem":["251919780","26750007"],"Wikipedia":["Methylsulfonylmethane"],"drugbank":["DB14090"],"chEBI":["9349"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255044","canonicalSmiles":"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N","inchiKey":"JUUFBMODXQKSTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPIRTINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flupirtine"],"crossReferences":{"PubChem":["11111201","124880149","174006272","90341043"],"Wikipedia":["Flupirtine"],"drugbank":["DB06623"]},"childChemblIds":["CHEMBL1256752","CHEMBL543869"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL261713","canonicalSmiles":"O=C(NO)[C@@H](Cc1ccc2ccccc2c1)NS(=O)(=O)c1ccc2ccccc2c1","inchiKey":"MMOUXLMPQFMDRD-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BB-78485","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BB-78485"],"crossReferences":{"drugbank":["DB07861"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL264950","canonicalSmiles":"O=[N+]([O-])c1ccc(-c2cc[nH]n2)cc1","inchiKey":"IPIYADCDDIUVPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL264950","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08695"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267225","canonicalSmiles":"C[C@H]1[C@H](C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@@H](O)[C@](C)(C(=O)O)[C@@H]5CC[C@]43C)[C@H]12","inchiKey":"NBGQZFQREPIKMG-PONOSELZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOSWELLIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beta-Boswellic Acid","Boswellic acid"],"crossReferences":{"PubChem":["26725249"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL295829","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)NO)c(C)n2C(=O)c1ccc(Cl)cc1","inchiKey":"AJRNYCDWNITGHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXAMETACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxametacin","Oxamethacin"],"crossReferences":{"Wikipedia":["Oxametacin"],"drugbank":["DB13308"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL300891","canonicalSmiles":"Cc1ccccc1CNC(=O)[C@H]1N(C(=O)[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cccc(O)c2C)CSC1(C)C","inchiKey":"CUFQBQOBLVLKRF-RZDMPUFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KNI-764","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KNI-764"],"crossReferences":{"drugbank":["DB02668"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039524","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.O=C(Nc1ccc(Cl)c(S(=O)(=O)N2CCNCC2)c1O)Nc1cccc(F)c1Cl","inchiKey":"CJAUWWGOABMMJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELUBRIXIN TOSYLATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL2178579","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elubrixin tosilate","Elubrixin tosylate","SB-656933-AAA"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL318153","canonicalSmiles":"CCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O","inchiKey":"XACKNLSZYYIACO-DJLDLDEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDOXUDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EDU","EUDR","Edoxudine","ORF 15817","RWJ 15817"],"crossReferences":{"PubChem":["144204943","56423684","855823"],"drugbank":["DB13421"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3184026","canonicalSmiles":"NC(N)=O.OO","inchiKey":"AQLJVWUFPCUVLO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3184026","maximumClinicalTrialPhase":0,"parentId":"CHEMBL985","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212768"],"drugbank":["DB11129"],"chEBI":["75178"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3187964","canonicalSmiles":"CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@H]1C","inchiKey":"UVAZQQHAVMNMHE-CZUORRHYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3187964","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206173"],"drugbank":["DB01473"]},"childChemblIds":["CHEMBL3246683"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3188549","canonicalSmiles":"C[C@@H]1O[C@@H]1P(=O)([O-])[O-].[Ca+2]","inchiKey":"YMZJBJPWTXJQMR-LJUKVTEVSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3188549","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1757","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204919"],"chEBI":["79400"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3188576","canonicalSmiles":"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"CZWJCQXZZJHHRH-YCRXJPFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROSTREPTOMYCIN SULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1950576","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Neurotoxicity"," Psychiatric toxicity"],"year":1970},"tradeNames":[],"synonyms":["Dihydrostreptomycin sulfate"],"crossReferences":{"PubChem":["144204862"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1970 due to Neurotoxicity and  Psychiatric toxicity."}
{"id":"CHEMBL325109","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1","inchiKey":"BVPWJMCABCPUQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEBOPRIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clanzoflat","Cleboril"],"synonyms":["Clebopride","Clebopride malate","LAS 9273"],"crossReferences":{"PubChem":["11112867"],"Wikipedia":["Clebopride"],"drugbank":["DB13511"]},"childChemblIds":["CHEMBL1599248"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000164270"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL33468","canonicalSmiles":"O=C(O)CCON=C1c2ccccc2-c2ccccc21","inchiKey":"LASWLEUVWJDDBA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL33468","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07240"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3421729","canonicalSmiles":"C[C@H]1c2cccc(CCC(C)(C)O)c2C[C@H](CO)N1C(=O)Cc1c(Cl)cccc1Cl","inchiKey":"XHCSBQBBGNQINS-DOTOQJQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEVIDALEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3154207","LY3154207","Ly3154207","Mevidalen"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL346455","canonicalSmiles":"Oc1ccc(CCNc2nc(SCCCc3ccc(Cl)cc3)nc(N3CCNCC3)n2)cc1","inchiKey":"AIBKIFHSQQYXLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL346455","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04020"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL350775","canonicalSmiles":"COc1cc(C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc2cccnc2)CCCc2cccnc2)cc(OC)c1OC","inchiKey":"CGVWPQOFHSAKRR-NDEPHWFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIRICODAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biricodar"],"crossReferences":{"Wikipedia":["Biricodar"],"drugbank":["DB04851"]},"childChemblIds":["CHEMBL2104406"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL354077","canonicalSmiles":"Nc1ccncc1N","inchiKey":"OYTKINVCDFNREN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMIFAMPRIDINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ruzurgi"],"synonyms":["3,4-DAP","3,4-Diammoniopyridinium","4-DAP","Amifampridine","DAP","NSC-521760","Pyridine-3,4-Diamine"],"crossReferences":{"DailyMed":["amifampridine","amifampridine%20phosphate"],"PubChem":["144206108","170466846","50112814","51088028","56323425"],"Wikipedia":["3,4-Diaminopyridine"],"drugbank":["DB11640"]},"childChemblIds":["CHEMBL3301611"],"count":2,"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000168263","ENSG00000129159","ENSG00000053918","ENSG00000140015","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000111262","ENSG00000102057","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000177301","ENSG00000158445","ENSG00000168418","ENSG00000089558","ENSG00000135519","ENSG00000151079","ENSG00000166006","ENSG00000104848","ENSG00000156486","ENSG00000184611","ENSG00000171385"],"count":40},"linkedDiseases":{"rows":["EFO_0008525","EFO_0003885","Orphanet_130","EFO_0009851","EFO_0004991","EFO_0005542"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 2 investigational indications."}
{"id":"CHEMBL3544991","drugType":"Antibody","blackBoxWarning":false,"name":"DOMAGROZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Domagrozumab","PF-06252616"],"count":1,"linkedTargets":{"rows":["ENSG00000138379"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545035","canonicalSmiles":"COCCCN1CC[C@@H](CNC(=O)c2cc(Cl)c(N)c3c2OC(C)(C)C3)[C@H](O)C1","inchiKey":"FOUUNSGQVBGYQM-SUMWQHHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REVEXEPRIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-149402","R149402","Revexepride","SPD-557","SPD557","Ssp-002358"],"count":1,"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["EFO_0003948"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545074","drugType":"Small molecule","blackBoxWarning":false,"name":"LEO-15520","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leo-15520"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545217","drugType":"Small molecule","blackBoxWarning":false,"name":"NS-018","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ilginatinib","NS-018","Ns-018"],"count":2,"linkedTargets":{"rows":["ENSG00000096968"],"count":1},"linkedDiseases":{"rows":["EFO_0002430","MONDO_0044903"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545323","drugType":"Small molecule","blackBoxWarning":false,"name":"PWT-33579","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pwt-33579"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707246","canonicalSmiles":"CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N.Cl","inchiKey":"HAOOCAKHSFYDBU-BDQAORGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OZANIMOD HYDROCHLORIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3707247","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zeposia"],"synonyms":["Ozanimod hydrochloride","RPC1063 HCL"],"crossReferences":{"DailyMed":["ozanimod%20hydrochloride"]},"count":1,"approvedIndications":["EFO_0003885"],"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["EFO_0003885"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for multiple sclerosis."}
{"id":"CHEMBL3707248","canonicalSmiles":"COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"BXGKAGLZHGYAMW-TZYFFPFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALBENAZINE TOSYLATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2364639","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ingrezza"],"synonyms":["NBI-98854","Valbenazine tosylate"],"crossReferences":{"DailyMed":["valbenazine%20tosylate"]},"count":1,"approvedIndications":["EFO_0004280"],"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["EFO_0004280"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for movement disorder."}
{"id":"CHEMBL3707305","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS ASCORBATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferrous ascorbate","J290.062I"],"crossReferences":{"DrugCentral":["4540"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707365","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"BEMIPARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bemiparin"],"crossReferences":{"DrugCentral":["4840"]},"count":5,"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL375492","canonicalSmiles":"CC(=O)Nc1ccc(/C=N/NC(N)=S)cc1","inchiKey":"SRVJKTDHMYAMHA-WUXMJOGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMITHIOZONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amithiozone","NSC-3550","SQ-2321","TB I-698","Thiacetazone","Thioacetazone"],"crossReferences":{"PubChem":["144205178","144205179","170466436","26754478","29215319"],"Wikipedia":["Thioacetazone"],"drugbank":["DB12829"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL376505","canonicalSmiles":"CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1","inchiKey":"SLPJGDQJLTYWCI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL376505","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26753546","26753547","90340899"],"drugbank":["DB04719"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL382127","canonicalSmiles":"NCC1(c2ccccc2)CCCC1","inchiKey":"SJWOFBVBNFLWLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(1-Phenylcyclopentyl)Methanamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(1-Phenylcyclopentyl)Methanamine"],"crossReferences":{"drugbank":["DB04577"],"chEBI":["39505"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833333","canonicalSmiles":"C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O.CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21","inchiKey":"SSNHGLKFJISNTR-DYSNNVSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NABIXIMOLS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sativex"],"synonyms":["Cannabinoids","GW 1000","GW 1000-02","GW-1000","Nabiximols","SAB 378","SAB-378"],"crossReferences":{"DrugCentral":["4793"],"drugbank":["DB14011"]},"count":12,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL389507","canonicalSmiles":"O=C(Nc1ccc(O)cc1)c1ccccc1O","inchiKey":"LGCMKPRGGJRYGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSALMID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-1718","NSC-93960","Osalmid"],"crossReferences":{"PubChem":["144205467","29216264"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3935857","canonicalSmiles":"Nc1nc2cc(-c3ccc4ncc(C(=O)N5CCOCC5)n4c3)ccc2o1","inchiKey":"BLGWHBSBBJNKJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERABELISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-PC-0DB6FL","INK1117","MLN-1117","MLN1117","Mln-1117","Serabelisib","TAK-117","Tak-117"],"crossReferences":{"drugbank":["DB14935"]},"count":5,"linkedTargets":{"rows":["ENSG00000121879"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000681","EFO_0004230","EFO_0003060","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3963485","canonicalSmiles":"COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1","inchiKey":"HNLRRJSKGXOYNO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROGARATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1163877","Bay-1163877","Rogaratinib"],"crossReferences":{"drugbank":["DB15078"]},"count":6,"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0008528","EFO_0006544","EFO_0000707","EFO_0003060","MONDO_0001187","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3989555","canonicalSmiles":"Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1.Cl.Cl.O","inchiKey":"KDLHYOMCWBWLMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECLIZINE HYDROCHLORIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1623","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ancoloxin","Antivert","Meclizine hydrochloride","Sea-legs","Traveleeze"],"synonyms":["Meclizine hydrochloride","Meclozine hydrochloride"],"crossReferences":{"DailyMed":["meclizine%20hydrochloride"]},"count":2,"approvedIndications":["EFO_0006928","HP_0002321"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0006928","HP_0002321","HP_0002013"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for motion sickness and vertigo."}
{"id":"CHEMBL3989767","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O","inchiKey":"BBBFJLBPOGFECG-VJVYQDLKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CALCITONIN SALMON","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcimar","Calcitonin-salmon","Miacalcin"],"synonyms":["Calcitonin salmon"],"crossReferences":{"DailyMed":["calcitonin%20salmon"]},"count":5,"approvedIndications":["EFO_0004261","EFO_0003854","HP_0003072"],"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["EFO_0004261","EFO_0005687","EFO_0003931","EFO_0003854","EFO_0003821","EFO_0003882","EFO_0003843","EFO_0003922","HP_0003072"],"count":9},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL3989768","canonicalSmiles":"CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13.O.O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"UMZNDVASJKIQCB-SODJFYQGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVORPHANOL TARTRATE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL592","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dromoran","Levo-dromoran","Levorphanol tartrate"],"synonyms":["Levorphanol tartrate"],"crossReferences":{"DailyMed":["levorphanol%20tartrate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991. This drug has a black box warning from the FDA."}
{"id":"CHEMBL405730","canonicalSmiles":"Cc1cn([C@H]2C=C[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"LXCAIISEDMYORY-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL405730","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02569"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297266","canonicalSmiles":"CCCCC[C@@H](O)/C=C/c1ccccc1/C=C/[C@@H](O)[C@@H](O)CCCC(=O)O","inchiKey":"HEDVTGFTYROYFE-RREUNBNVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BLXA4","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BLXA-4","Blxa4"],"crossReferences":{"drugbank":["DB12133"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297294","canonicalSmiles":"O=C(Nc1cnccc1Cl)N1CCN(Cc2ccc3c(c2)OC(F)(F)O3)CC1","inchiKey":"YWGYNGCRVZLMCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-42165279","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-42165279"],"crossReferences":{"drugbank":["DB15173"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297314","canonicalSmiles":"C1COCN1","inchiKey":"WYNCHZVNFNFDNH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXAZOLIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxazolidine"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297338","canonicalSmiles":"Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2[18F])c(=O)[nH]c1=O","inchiKey":"GBBJCSTXCAQSSJ-MSYRQUNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-METHYL-2'-FLUOROARAURACIL F-18","maximumClinicalTrialPhase":1,"parentId":"CHEMBL475717","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["18f-fmau","5-methyl-2'-fluoroarauracil f-18","J2.616.188F"],"crossReferences":{"drugbank":["DB14913"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297387","canonicalSmiles":"C[C@@H](c1cc(Cl)cc2ccccc12)N(C)C(=O)CC1(c2ccc(F)cc2)CCN(C)CC1","inchiKey":"DRXBWLBZWAJIEF-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-424887","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK424887","Gsk-424887","Gsk424887"],"crossReferences":{"drugbank":["DB12219"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297604","canonicalSmiles":"O=C(O)c1ccc(CN2C[C@@H]3C[C@H]2CN3Cc2ccc(Oc3ccc(-c4ncco4)cc3)cc2)cc1","inchiKey":"GERJIEKMNDGSCS-DQEYMECFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEBILUSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acebilustat","CTX-4430","Ctx-4430","EP-501"],"crossReferences":{"drugbank":["DB15385"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297617","canonicalSmiles":"CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N2","inchiKey":"CQXYENUJCPYPTI-LZUXSVOASA-N","drugType":"Protein","blackBoxWarning":false,"name":"MIBENRATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-54452840","Jnj-54452840","Mibenratide"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297740","drugType":"Protein","blackBoxWarning":false,"name":"DARLEUKIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darleukin","L19-il2","L19IL2"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297809","drugType":"Unknown","blackBoxWarning":false,"name":"PF-06863135","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06863135","Pf-06863135"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297936","drugType":"Unknown","blackBoxWarning":false,"name":"RECOMBINANT HUMAN KALLIKREIN-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DM-199","DM199","Dm199","Recombinant human kallikrein-1"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297956","drugType":"Unknown","blackBoxWarning":false,"name":"FS-102","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986186","FS-102","FS102","Fs-102","Fs102"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298067","drugType":"Antibody","blackBoxWarning":false,"name":"TOMARALIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OPN-305","Opn 305","Opn-305","Tomaralimab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298123","drugType":"Antibody","blackBoxWarning":false,"name":"COBOLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cobolimab","TSR-022","Tsr 022","Tsr-022","WBP-296A"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4303360","canonicalSmiles":"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O.O.O","inchiKey":"ARXXWSPWNHULSJ-GCZBSULCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303360","maximumClinicalTrialPhase":0,"parentId":"CHEMBL177","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL44354","canonicalSmiles":"CC(C)(O/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)O","inchiKey":"ORFOPKXBNMVMKC-DWVKKRMSSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CEFTAZIDIME","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceftazidime","Ceptaz","Fortam","Fortaz","Fortum","Kefazim","Pentacef","Tazicef","Tazidime"],"synonyms":["Ceftazidime","Ceftazidime (arginine formulation)","Ceftazidime hydrate","Ceftazidime pentahydrate","Ceptaz","Fortaz","GR 20263","GR-20263","J01DD07","LY 139381","LY-139381","Pentacef","Tazicef","Tazidime"],"crossReferences":{"DailyMed":["ceftazidime"],"drugbank":["DB00438"],"chEBI":["3508"]},"childChemblIds":["CHEMBL3186392","CHEMBL1200768"],"count":11,"approvedIndications":["EFO_0003103","EFO_0000771","EFO_0008588","EFO_0000544","EFO_1001141"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 5 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL453388","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O.O.O.O","inchiKey":"RXDALBZNGVATNY-CWLIKTDRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPICILLIN TRIHYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL174","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ampicillin/ampicillin monohydrate","Ampicillin/ampicillin trihydrate","BRL-1341"],"crossReferences":{"PubChem":["144208346","17390044"],"chEBI":["31209"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594320","drugType":"Enzyme","blackBoxWarning":false,"name":"AVALGLUCOSIDASE ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avalglucosidase alfa","GZ-402666","GZ402666","Gz402666","neoGAA"],"count":2,"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594432","canonicalSmiles":"CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccn1","inchiKey":"PNPFMWIDAKQFPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-3200882","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3200882","LY3200882","Ly-3200882","Ly3200882"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594506","drugType":"Unknown","blackBoxWarning":false,"name":"TERN-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2562175","LY2562175","TERN-101","Tern-101"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594613","drugType":"Unknown","blackBoxWarning":false,"name":"VIS-410","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VIS410","Vis-410","Vis410"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL461346","canonicalSmiles":"CCOc1ccc(NC(C)=O)cc1.Cl","inchiKey":"CXYXZHZOAVMRDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENACETIN CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL16073","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenacetin HCl"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL477278","canonicalSmiles":"N[C@@H](Cc1ccc(OCC[18F])cc1)C(=O)O","inchiKey":"QZZYPHBVOQMBAT-LRAGLOQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL477278","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1908892","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15405"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL482968","canonicalSmiles":"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1","inchiKey":"BLQYVHBZHAISJM-CMDGGOBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENMD-2076","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ENMD-2076","Enmd 2076","Enmd-2076"],"childChemblIds":["CHEMBL3237191"],"count":10,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000128052","ENSG00000068078","ENSG00000178999","ENSG00000157404","ENSG00000182578","ENSG00000122025"],"count":7},"linkedDiseases":{"rows":["EFO_0000348","EFO_0001642","MONDO_0008170","EFO_1000251","EFO_0000182","MONDO_0007254","EFO_1001968","EFO_0001378","MONDO_0002087","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL486921","canonicalSmiles":"O=C1OCC/C1=C\\Nc1ccccc1","inchiKey":"BKXNPYSVWOVZGX-CMDGGOBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL486921","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07317"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL494397","canonicalSmiles":"C/N=C(\\N)N(C)C(=N)N.Cl","inchiKey":"GWWIHNWMWIJWRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METFORMIN XR","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1187231","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metformin xr"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL523299","canonicalSmiles":"OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2.[Br-]","inchiKey":"PEJHHXHHNGORMP-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"UMECLIDINIUM BROMIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1187833","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Incruse ellipta"],"synonyms":["GSK-573719A","GSK573719A","Umeclidinium brom","Umeclidinium bromide"],"crossReferences":{"DailyMed":["umeclidinium%20bromide"]},"count":5,"approvedIndications":["HP_0006536","EFO_0000464","EFO_0006505","EFO_0000341"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000270","EFO_0000464","EFO_0006505","EFO_0000341"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 4 approved and 1 investigational indication."}
{"id":"CHEMBL534","canonicalSmiles":"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1","inchiKey":"ZCVMWBYGMWKGHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KETOTIFEN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(R)-Ketotifen","Ketotifen"],"crossReferences":{"DailyMed":["ketotifen%20fumarate"],"PubChem":["104171180","11111350","11111351","11113338","144203727","170465378","26751502","50100258","50104048","90341121"],"Wikipedia":["Ketotifen"],"drugbank":["DB00920"]},"childChemblIds":["CHEMBL1885671","CHEMBL1633"],"count":8,"approvedIndications":["EFO_0005751","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005687","HP_0012532","EFO_0007425","HP_0001371","EFO_0000274","EFO_0008533","EFO_0003931","EFO_0000270","MONDO_0002406","EFO_0009521","EFO_0007141","EFO_0005751","EFO_1001417","EFO_0003785"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for eye allergy and allergy and has 6 investigational indications."}
{"id":"CHEMBL550495","canonicalSmiles":"CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.O.O.O.[Cl-]","inchiKey":"XQAXGZLFSSPBMK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"METHYLENE BLUE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL191083","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Provayblue","Urolene blue"],"synonyms":["C.I. 52015","CI 52015","CI-52015","Methylene blue","Methylene blue trihydrate","Methylthionine chloride","Methylthionine hydrochloride","Methylthioninium chloride","NSC-215213","NSC-617593","Trx0014"],"crossReferences":{"PubChem":["144209723","17388909"]},"count":15,"approvedIndications":["EFO_0003103"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for urinary tract infection and has 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL55612","canonicalSmiles":"CCC[C@H](N)C(=O)O","inchiKey":"SNDPXSYFESPGGJ-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORVALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Amino-Pentanoic Acid","L-Norvaline"],"crossReferences":{"Wikipedia":["Norvaline"],"drugbank":["DB04185"],"chEBI":["18314"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL559478","canonicalSmiles":"O=C(Oc1ccc(Br)cc1)N1CCN2CCC1CC2","inchiKey":"RXLOZRCLQMJJLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SSR180711","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J2.849.107G","SSR-180711","SSR180711C","Ssr180711"],"crossReferences":{"PubChem":["144210561"]},"childChemblIds":["CHEMBL3235499"],"count":1,"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL608393","canonicalSmiles":"Cn1ccnc1Sc1cc(C(=O)Nc2nccs2)c(N)cc1F","inchiKey":"YUCYMQBDBXVNCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL608393","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08210"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6437","canonicalSmiles":"CN1CCN2c3ccccc3Cc3ccccc3C2C1","inchiKey":"UEQUQVLFIPOEMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIANSERIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["J16.389I","Mianserin"],"crossReferences":{"PubChem":["104171186","124880671","144203742","170465596","26752015","50104682","90341017"],"Wikipedia":["Mianserin"],"drugbank":["DB06148"],"chEBI":["51137"]},"childChemblIds":["CHEMBL544428"],"count":4,"approvedIndications":["EFO_0003761"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for unipolar depression and has 3 investigational indications."}
{"id":"CHEMBL647","canonicalSmiles":"Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1","inchiKey":"IEJXVRYNEISIKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRACLONIDINE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iopidine"],"synonyms":["Apraclonidine"],"crossReferences":{"DailyMed":["apraclonidine%20hydrochloride"],"PubChem":["11110712","50110931","90341674"],"Wikipedia":["Apraclonidine"],"drugbank":["DB00964"],"chEBI":["2788"]},"childChemblIds":["CHEMBL1200379"],"count":1,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and is indicated for glaucoma."}
{"id":"CHEMBL65061","canonicalSmiles":"CCCCC/C=C\\C[C@@H](O)/C=C/C=C/C=C\\[C@@H](O)CCCC(=O)O","inchiKey":"VNYSSYRCGWBHLG-AMOLWHMGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEUKOTRIENE_B4","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leukotriene B4"],"crossReferences":{"PubChem":["26754792"],"Wikipedia":["Leukotriene_B4"],"drugbank":["DB12961"],"chEBI":["15647"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL66280","canonicalSmiles":"C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"NTXUAWGNGBSCRS-TZQXKBMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-IODO,5'-DEOXYTUBERCIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Iodo,5'-Deoxytubercidin"],"crossReferences":{"drugbank":["DB07173"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL685","canonicalSmiles":"COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1","inchiKey":"OPXLLQIJSORQAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBENDAZOLE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emverm","Mebendazole","Mebenvet","Ovex","Telmin","Telmintic","Vermox"],"synonyms":["Mebendazole","Mebendazole polymorph c","NSC-184849","R 17,635","R-17635"],"crossReferences":{"DailyMed":["mebendazole"],"PubChem":["11112718","124882564","144204171","170464914","174007187","26746927","855610"],"Wikipedia":["Mebendazole"],"drugbank":["DB00643"],"chEBI":["6704"]},"count":7,"approvedIndications":["EFO_1001342"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for helminthiasis and has 6 investigational indications."}
{"id":"CHEMBL698","canonicalSmiles":"CCCCNc1ccc(C(=O)OCCN(C)C)cc1","inchiKey":"GKCBAIGFKIBETG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRACAINE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ametop","Dicaine","Medihaler-tetracaine","Metraspray","Pontocaine"],"synonyms":["Amethocaine","Tetracaine"],"crossReferences":{"DailyMed":["tetracaine","tetracaine%20hydrochloride"],"PubChem":["11111916","11111917","50111267","90340576"],"Wikipedia":["Tetracaine"],"drugbank":["DB09085"],"chEBI":["9468"]},"childChemblIds":["CHEMBL1255654"],"count":10,"approvedIndications":["HP_0000989","EFO_0009552","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0001059","HP_0000989","EFO_0009540","EFO_1001178","EFO_0000701","EFO_1001054","EFO_0003843","EFO_0000546","EFO_0003885","EFO_0002506","HP_0030834","EFO_0004143","EFO_0006510","EFO_0009552","EFO_1001887","EFO_1001434"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 approved and 7 investigational indications."}
{"id":"CHEMBL710","canonicalSmiles":"CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"DBEPLOCGEIEOCV-WSBQPABSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FINASTERIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aindeem","Finasteride","Propecia","Proscar","Prostide"],"synonyms":["Finasteride","MK-906"],"crossReferences":{"DailyMed":["finasteride"],"PubChem":["144204268","144208704","144213061","170464818","26719811","26753508","26753509","49666458"],"Wikipedia":["Finasteride"],"drugbank":["DB01216"],"chEBI":["5062"]},"count":10,"approvedIndications":["Orphanet_79364","EFO_0000673","EFO_0000284","EFO_0004191","EFO_0001663"],"linkedTargets":{"rows":["ENSG00000277893"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","Orphanet_79364","EFO_0000673","EFO_0003839","EFO_0000284","EFO_0003894","EFO_0004191","MONDO_0008315","EFO_0003877","EFO_0001663","EFO_0003060"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 5 approved and 5 investigational indications."}
{"id":"CHEMBL741","canonicalSmiles":"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1","inchiKey":"PYZRQGJRPPTADH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LAMOTRIGINE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lamictal","Lamictal cd","Lamictal odt","Lamictal xr","Lamotrigine"],"synonyms":["BW 430C","BW-430C","Lamotrigine"],"crossReferences":{"DailyMed":["lamotrigine"],"PubChem":["11113342","144203730","170465024","174006315","26719658","50104089","56423136","85231112","855818","90341162"],"Wikipedia":["Lamotrigine"],"drugbank":["DB00555"],"chEBI":["6367"]},"count":24,"approvedIndications":["HP_0002069","EFO_0000289","EFO_0000474","EFO_0004263","EFO_0003761","HP_0001250","Orphanet_2382"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0002610","EFO_1001219","MONDO_0002009","HP_0000726","HP_0100543","EFO_0004247","EFO_0000289","EFO_0000474","MONDO_0002050","EFO_0004263","EFO_0003100","EFO_1000632","EFO_0003761","EFO_0006510","EFO_0005230","EFO_0000692","EFO_0008522","HP_0002069","EFO_0005203","EFO_0005039","HP_0012076","EFO_0000677","Orphanet_636","EFO_0009963","EFO_0003929","HP_0001250","Orphanet_2382","Orphanet_64280","EFO_0001073","EFO_0003843","EFO_0001072","EFO_0003890","Orphanet_79292","EFO_0000270","EFO_0000764","EFO_0005611","EFO_0007262"],"count":37},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 7 approved and 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL75094","canonicalSmiles":"CC1(C)SCCN(S(=O)(=O)c2ccc(Oc3ccncc3)cc2)[C@H]1C(=O)NO","inchiKey":"YKPYIPVDTNNYCN-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRINOMASTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-3340","AG3340","KB-R-9896","Prinomastat"],"crossReferences":{"Wikipedia":["Prinomastat"],"drugbank":["DB05100"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL753","canonicalSmiles":"CC(COc1ccccc1)N(CCCl)Cc1ccccc1","inchiKey":"QZVCTJOXCFMACW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOXYBENZAMINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Phenoxybenzamine"],"crossReferences":{"DailyMed":["phenoxybenzamine%20hydrochloride"],"PubChem":["104171113","124879342","124879343","144203638","170465147","174007411","26752309","26752310","90341231"],"Wikipedia":["Phenoxybenzamine"],"drugbank":["DB00925"],"chEBI":["8077"]},"childChemblIds":["CHEMBL1200787"],"count":2,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0005207","EFO_0000319","EFO_0000239"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL85943","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM TUNGSTATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sodium tungstate","Sodium tungstate(vi)"],"crossReferences":{"chEBI":["63940"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL87647","canonicalSmiles":"Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(CO)c1Br","inchiKey":"LSIZSSASMKSUIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-185545","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-185545"],"crossReferences":{"drugbank":["DB06874"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL9225","canonicalSmiles":"CC[C@H](c1ccc(O)cc1)[C@@H](CC)c1ccc(O)cc1","inchiKey":"PBBGSZCBWVPOOL-HDICACEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESO-HEXESTROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexestrol"],"crossReferences":{"PubChem":["11112224","144203928","144211773","170466031"],"drugbank":["DB07931"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL930","canonicalSmiles":"NC(=O)CC[C@H](N)C(=O)O","inchiKey":"ZDXPYRJPNDTMRX-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTAMINE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Endari","Nutrestore"],"synonyms":["FEMA NO. 3684","Glutamine","L-glutamine","Levoglutamide","NSC-27421"],"crossReferences":{"DailyMed":["l-glutamine"],"PubChem":["26747519","50106343","90341595"],"Wikipedia":["Glutamine"],"drugbank":["DB00130"],"chEBI":["18050"]},"count":33,"approvedIndications":["Orphanet_365563"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for primary short bowel syndrome and has 32 investigational indications."}
{"id":"CHEMBL93077","canonicalSmiles":"O=C(C[S+]([O-])C(c1ccccc1)c1ccccc1)NO","inchiKey":"CGNMLOKEMNBUAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADRAFINIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adrafinil"],"crossReferences":{"PubChem":["144205811","29217469","50111697"],"Wikipedia":["Adrafinil"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL9519","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1","inchiKey":"QHWZTVCCBMIIKE-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL9519","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03413"],"chEBI":["28850"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL95681","canonicalSmiles":"O=C1CCCO1","inchiKey":"YEJRWHAVMIAJKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYROLACTONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gama-Butyrolactone"],"crossReferences":{"PubChem":["144207688","144210508"],"Wikipedia":["Gamma-Butyrolactone"],"drugbank":["DB04699"],"chEBI":["42639"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL96783","canonicalSmiles":"OC[C@H](O)[C@@H](O)[C@H](O)CO","inchiKey":"HEBKCHPVOIAQTA-SCDXWVJYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XYLITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-967","E967","INS NO.967","INS-967","NSC-25283","Xylitol"],"crossReferences":{"PubChem":["144208254"],"Wikipedia":["Xylitol"],"drugbank":["DB11195"],"chEBI":["17151"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL99203","canonicalSmiles":"Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"WHSIXKUPQCKWBY-IOSLPCCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOTUBERCIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Iodotubercidine"],"crossReferences":{"drugbank":["DB04604"],"chEBI":["40167"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
